CDTI Innovación's INNVIERTE program
VC Fund
Madrid, Spain
CDTI Innovación's INNVIERTE program is a VC fund in Madrid focused on Biotechnology and Health Care. CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
- Total investments:
- 55
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries CDTI Innovación's INNVIERTE program invests in
Stages CDTI Innovación's INNVIERTE program invests in
Countries CDTI Innovación's INNVIERTE program invests in
Round sizes
Round size
- Seed
- $266k–$6.4M
- Grant
- $260k–$1.1M
- Venture - Series Unknown
- $330k–$16M
Investment Focus
Industry
- Biotechnology 15 (27%)
- Health Care 10 (18%)
- Medical 8 (15%)
- Software 5 (9%)
- Life Science 4 (7%)
Stage
- Venture - Series Unknown 18 (33%)
- Seed 16 (29%)
- Grant 5 (9%)
- Series A 4 (7%)
- Funding Round 4 (7%)
Country
- Spain 43 (78%)
- Panama 1 (2%)
- Switzerland 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Accexible
|
Accexible focuses on the development of technology that extracts acoustic characteristics from the speech of a person who gives us clues to his health and well-being. Accexible identifies vocal biomarkers, specific characteristics of the voice that indicate various health conditions, for the diagnosis and monitoring of diseases | Grant / Sep 09, 2026 | |
Deneb Medical
|
Deneb Medical is to create innovative, game-changing medical solutions. | $17.1M / Series A / Sep 08, 2026 | |
Ancavico
|
Ancavico is a seafood production company that offers deep-frozen products, fish, cephalopods, seafood mixes, and salads. | Grant / Aug 20, 2026 | |
Telum Therapeutics
|
Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages. | $20.5M / Series A / Jul 01, 2026 | |
Ona Therapeutics
|
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine. | $86.6M / Series B / Jun 04, 2026 | |
Zoundream
|
Babies cry sounds convey a massive stream of information: its needs, emotions, well-being, and physical status. Indeed, it’s the only way small babies have to communicate with the external world.In Zoundream, we use cutting edge developments in sound recognition, to the specific field of baby cries. Our technology can not only translate cries inreal time (e.g. hungry, sleepy), but also identify potential pathologies – improving well-being of families and babies, all around the world. | $761.5K / Venture - Series Unknown / May 05, 2026 | |
MOA
|
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food. | Venture - Series Unknown / Apr 27, 2026 | |
LuxQuanta
|
Bringing quantum-safe cryptography to the Telecommunication industry | $1M / Venture - Series Unknown / Apr 13, 2026 | |
Golden Owl
|
Golden Owl is an AI-powered business intelligence platform that delivers real-time insights through AI agents and open-source intelligence. It provides AI-driven business intelligence and risk analysis using a network of specialized AI agents. The platform gathers and analyzes open-source data to help organizations monitor markets, competitors,threats, and opportunities. It enables faster decision-making through automated intelligence collection, analytics, and conversational AI-powered insights. | Grant / Apr 09, 2026 | |
Molecular Gate
|
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease. | $526.3K / Seed / Mar 02, 2026 | |
| See all 55 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CDTI Innovación's INNVIERTE program invest in?
CDTI Innovación's INNVIERTE program invests primarily in Biotechnology, Health Care and Medical startups, most often at Venture - Series Unknown and Seed stage. Most of the 55 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CDTI Innovación's INNVIERTE program's check size?
CDTI Innovación's INNVIERTE program typically joins rounds of $266k–$6.4M at Seed, $260k–$1.1M at Grant and $330k–$16M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CDTI Innovación's INNVIERTE program participates in.
When did CDTI Innovación's INNVIERTE program last invest?
The most recent investment recorded for CDTI Innovación's INNVIERTE program closed in Sep 2026. Shizune tracks 55 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
